Victor Bykov

1.0k total citations
32 papers, 875 citations indexed

About

Victor Bykov is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Victor Bykov has authored 32 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in Victor Bykov's work include Neuropeptides and Animal Physiology (30 papers), Receptor Mechanisms and Signaling (27 papers) and Pharmacological Receptor Mechanisms and Effects (23 papers). Victor Bykov is often cited by papers focused on Neuropeptides and Animal Physiology (30 papers), Receptor Mechanisms and Signaling (27 papers) and Pharmacological Receptor Mechanisms and Effects (23 papers). Victor Bykov collaborates with scholars based in United States, Czechia and Singapore. Victor Bykov's co-authors include Richard B. Rothman, Kenner C. Rice, John W. Holaday, Arthur E. Jacobson, Joseph B. Long, Arthur E. Jacobson, Brian R. de Costa, Linda S. Brady, K.C. Rice and H. Y. Xu and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Victor Bykov

32 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor Bykov United States	17	802	718	205	22	21	32	875
Peter J. Horan United States	12	543 0.7×	447 0.6×	249 1.2×	25 1.1×	24 1.1×	14	653
Lynne Miller United Kingdom	10	521 0.6×	511 0.7×	187 0.9×	12 0.5×	37 1.8×	16	645
Erik Mansson United States	9	419 0.5×	362 0.5×	173 0.8×	32 1.5×	21 1.0×	12	547
Antonia Mattia United States	10	505 0.6×	388 0.5×	247 1.2×	21 1.0×	21 1.0×	12	591
D. Roemer Japan	8	461 0.6×	436 0.6×	189 0.9×	24 1.1×	28 1.3×	14	673
Lee-Yuan Liu-Chen United States	14	438 0.5×	423 0.6×	116 0.6×	47 2.1×	20 1.0×	23	621
Yoshikazu Katao Japan	7	494 0.6×	436 0.6×	154 0.8×	9 0.4×	26 1.2×	7	533
K. Spiegel United States	9	299 0.4×	293 0.4×	166 0.8×	41 1.9×	30 1.4×	11	497
Hiroshi Nagase Japan	10	313 0.4×	223 0.3×	139 0.7×	15 0.7×	16 0.8×	13	418
L. Cubeddu United States	12	267 0.3×	360 0.5×	124 0.6×	43 2.0×	25 1.2×	15	587

Countries citing papers authored by Victor Bykov

Since Specialization

Citations

This map shows the geographic impact of Victor Bykov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Bykov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Bykov more than expected).

Fields of papers citing papers by Victor Bykov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Bykov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Bykov. The network helps show where Victor Bykov may publish in the future.

Co-authorship network of co-authors of Victor Bykov

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Bykov. A scholar is included among the top collaborators of Victor Bykov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Bykov. Victor Bykov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rothman, Richard B., Victor Bykov, H. Y. Xu, et al.. (1992). Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences. Peptides. 13(5). 977–987. 41 indexed citations

Mahboubi, Artin, et al.. (1992). Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that μ ligands are noncompetitive inhibitors of the δcx opioid peptide binding site. Peptides. 13(6). 1137–1143. 14 indexed citations

Rothman, Richard B., et al.. (1992). A study of the effect of the irreversible delta receptor antagonist [d-Ala2,Leu5,Cys6]Enkephalin on and opioid binding sites in vitro and in vivo. Peptides. 13(4). 691–694. 10 indexed citations

Rothman, Richard B., Joseph B. Long, Victor Bykov, et al.. (1991). Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence. Peptides. 12(1). 151–160. 54 indexed citations

Rothman, Richard B., et al.. (1991). Probing the opioid receptor complex with (+)-trans-superfit. I. Evidence that [D-Pen2,D-Pen5]enkephalin interacts with high affinity at the δcx binding site. Peptides. 12(2). 359–364. 14 indexed citations

Bykov, Victor, Artin Mahboubi, Joseph B. Long, et al.. (1991). Interaction of β‐funaltrexamine with [³H]cycloFOXY binding in rat brain: Further evidence that β‐FNA alkylates the opioid receptor complex. Synapse. 8(2). 86–99. 22 indexed citations

Rothman, Richard B., Victor Bykov, Brian R. de Costa, et al.. (1990). Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides. 11(2). 311–331. 130 indexed citations

Rothman, Richard B., Joseph B. Long, Victor Bykov, et al.. (1990). Pretreatment of rats with the irreversible μ-receptor antagonist, β-FNA, fails to prevent naltrexone-induced upregulation of μ-opioid receptors. Neuropharmacology. 29(9). 805–810. 9 indexed citations

Band, Linda C., H. Y. Xu, Victor Bykov, et al.. (1990). The potent opioid agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: Evidence for a novel mechanism of action. Life Sciences. 47(24). 2231–2240. 7 indexed citations

10.

Costa, Brian R. de, Richard B. Rothman, Victor Bykov, et al.. (1990). Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands. Journal of Medicinal Chemistry. 33(4). 1171–1176. 9 indexed citations

11.

Rothman, Richard B., Arthur E. Jacobson, Mariena V. Mattson, et al.. (1989). Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for the .delta.-opioid receptors in vitro. Journal of Medicinal Chemistry. 32(6). 1392–1398. 20 indexed citations

12.

Costa, Brian R. de, et al.. (1989). Selective and enantiospecific acylation of .kappa.-opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide. Demonstration of .kappa. receptor heterogeneity. Journal of Medicinal Chemistry. 32(2). 281–283. 27 indexed citations

13.

Costa, Brian R. de, Linda C. Band, Richard B. Rothman, et al.. (1989). Synthesis of an affinity ligand (‘UPHIT’) for in vivo acylation of the κ‐opioid receptor. FEBS Letters. 249(2). 178–182. 10 indexed citations

14.

Rothman, Richard B., Victor Bykov, Joseph B. Long, et al.. (1989). Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites. European Journal of Pharmacology. 160(1). 71–82. 76 indexed citations

15.

Rothman, Richard B., Victor Bykov, Danielle Ofri, & Kenner C. Rice. (1988). LY164929: a highly selective ligand for the lower affinity [3H]D-Ala2-D-Leu-5-enkephalin binding site. Neuropeptides. 11(1). 13–16. 18 indexed citations

16.

Rothman, Richard B., et al.. (1988). Tritiated-6-beta-fluoro-6-desoxy-oxymorphone 〈[3H] FOXY〉: a new ligand and photoaffinity probe for the MU opioid receptors. Neuropeptides. 11(1). 1–6. 10 indexed citations

17.

Rothman, Richard B., Victor Bykov, Audrey A. Reid, et al.. (1988). A brief study of the selectivity of norbinaltorphimine, (−)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro. Neuropeptides. 12(3). 181–187. 24 indexed citations

18.

Rothman, Richard B., Stafford McLean, Victor Bykov, et al.. (1987). Chronic morphine upregulates a μ-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography. European Journal of Pharmacology. 142(1). 73–81. 29 indexed citations

19.

Rothman, Richard B., Victor Bykov, Jean Lud Cadet, & Joel E. Kleinman. (1987). A postmortem study of the effect of chronic opiate abuse on psychotomimetic binding sites of human frontal cortex. Neuropeptides. 10(3). 261–264. 3 indexed citations

20.

Byrd, James C., Victor Bykov, & Richard B. Rothman. (1987). Rat brain PCP receptors: Alterations in binding parameters following chronic administration of opiate agonists and antagonists. Neuropeptides. 10(2). 201–205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact